These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15226040)
1. Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening program for ovarian cancer. Salsman JM; Pavlik E; Boerner LM; Andrykowski MA Prev Med; 2004 Aug; 39(2):315-22. PubMed ID: 15226040 [TBL] [Abstract][Full Text] [Related]
2. Psychological response to test results in an ovarian cancer screening program: a prospective, longitudinal study. Andrykowski MA; Boerner LM; Salsman JM; Pavlik E Health Psychol; 2004 Nov; 23(6):622-30. PubMed ID: 15546230 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with return for routine annual screening in an ovarian cancer screening program. Andrykowski MA; Zhang M; Pavlik EJ; Kryscio RJ Gynecol Oncol; 2007 Mar; 104(3):695-701. PubMed ID: 17145075 [TBL] [Abstract][Full Text] [Related]
4. Demographic, clinical, dispositional, and social-environmental characteristics associated with psychological response to a false positive ovarian cancer screening test: a longitudinal study. Wiggins AT; Pavlik EJ; Andrykowski MA J Behav Med; 2018 Jun; 41(3):277-288. PubMed ID: 29071653 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341 [TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer screening in women with a family history of breast or ovarian cancer. Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240 [TBL] [Abstract][Full Text] [Related]
7. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital]. Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203 [TBL] [Abstract][Full Text] [Related]
8. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening. Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925 [TBL] [Abstract][Full Text] [Related]
9. Abnormal ovarian cancer screening test result: women's informational, psychological and practical needs. Ryan PY; Graves KD; Pavlik EJ; Andrykowski MA J Psychosoc Oncol; 2007; 25(4):1-18. PubMed ID: 18032262 [TBL] [Abstract][Full Text] [Related]
10. Psychological impact of screening for familial ovarian cancer. Wardle FJ; Collins W; Pernet AL; Whitehead MI; Bourne TH; Campbell S J Natl Cancer Inst; 1993 Apr; 85(8):653-7. PubMed ID: 8468723 [TBL] [Abstract][Full Text] [Related]
11. The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy. Pavlik EJ; Saunders BA; Doran S; McHugh KW; Ueland FR; Desimone CP; Depriest PD; Ware RA; Kryscio RJ; van Nagell JR Cancer; 2009 Aug; 115(16):3689-98. PubMed ID: 19603478 [TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668 [TBL] [Abstract][Full Text] [Related]
13. Illness representations and distress in women undergoing screening for familial ovarian cancer. Lancastle D; Brain K; Phelps C Psychol Health; 2011 Dec; 26(12):1659-77. PubMed ID: 21736431 [TBL] [Abstract][Full Text] [Related]
14. Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program. Lykins EL; Pavlik EL; Andrykowski MA Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):490-3. PubMed ID: 17372244 [TBL] [Abstract][Full Text] [Related]
15. Serum CA 125 combined with transvaginal ultrasonography for ovarian cancer screening. Roupa Z; Faros E; Raftopoulos V; Tzavelas G; Kotrotsiou E; Sotiropoulou P; Karanikola E; Skifta E; Ardavanis A In Vivo; 2004; 18(6):831-6. PubMed ID: 15646829 [TBL] [Abstract][Full Text] [Related]
16. A Pap test does not screen for everything: nurse practitioner knowledge of ovarian cancer. Loerzel VW; Hunt D; Rash E J Am Assoc Nurse Pract; 2015 Mar; 27(3):124-30. PubMed ID: 25044820 [TBL] [Abstract][Full Text] [Related]
17. Psychological and behavioral impact of receipt of a "normal" ovarian cancer screening test. Gaugler JE; Pavlik E; Salsman JM; Andrykowski MA Prev Med; 2006 Jun; 42(6):463-70. PubMed ID: 16563482 [TBL] [Abstract][Full Text] [Related]
18. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205 [TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography. Van Nagell JR; DePriest PD; Puls LE; Donaldson ES; Gallion HH; Pavlik EJ; Powell DE; Kryscio RJ Cancer; 1991 Aug; 68(3):458-62. PubMed ID: 2065264 [TBL] [Abstract][Full Text] [Related]
20. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. Menon U; Skates SJ; Lewis S; Rosenthal AN; Rufford B; Sibley K; Macdonald N; Dawnay A; Jeyarajah A; Bast RC; Oram D; Jacobs IJ J Clin Oncol; 2005 Nov; 23(31):7919-26. PubMed ID: 16258091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]